Glaukos: Q4 Earnings Snapshot [Yahoo! Finance]
Glaukos Corporation (GKOS)
Last glaukos corporation earnings: 2/27 04:15 pm
Check Earnings Report
US:NYSE Investor Relations:
investors.glaukos.com/investors/investor-overview/default.aspx
Company Research
Source: Yahoo! Finance
The Aliso Viejo, California-based company said it had a loss of 60 cents per share. Losses, adjusted for non-recurring costs, came to 40 cents per share. The results surpassed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of 43 cents per share. The glaucoma treatments developer posted revenue of $105.5 million in the period, also beating Street forecasts. Nine analysts surveyed by Zacks expected $100.8 million. For the year, the company reported a loss of $146.4 million, or $2.77 per share. Revenue was reported as $383.5 million. Glaukos expects full-year revenue in the range of $475 million to $485 million. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GKOS at https://www.zacks.com/ap/GKOS View Comments
Show less
Read more
Impact Snapshot
Event Time:
GKOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GKOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GKOS alerts
High impacting Glaukos Corporation news events
Weekly update
A roundup of the hottest topics
GKOS
News
- Glaukos (NYSE:GKOS) had its price target raised by analysts at Truist Financial Corporation from $120.00 to $145.00. They now have a "buy" rating on the stock.MarketBeat
- Glaukos (NYSE:GKOS) was given a new $165.00 price target on by analysts at UBS Group AG.MarketBeat
- Glaukos (NYSE:GKOS) had its "overweight" rating reaffirmed by analysts at Piper Sandler.MarketBeat
- Glaukos Announces Participation in J.P. Morgan Healthcare ConferenceBusiness Wire
- Glaukos (NYSE:GKOS) had its "buy" rating reaffirmed by analysts at Citigroup Inc..MarketBeat
GKOS
Earnings
- 10/29/25 - Beat
GKOS
Sec Filings
- 12/15/25 - Form 4
- 12/15/25 - Form 4
- 12/15/25 - Form 4
- GKOS's page on the SEC website